Disclosed is an in vitro screening method for identifying an antagonist-to-agonist allosteric modifier of a mu-opioid receptor and an in vivo method for confirming that a test compound is such a modifier of a mu-opioid receptor. Also disclosed is a method for treating an opioid receptor-associated condition using a compound of Formula (I) and a pharmaceutical composition containing the same.
[EN] OPIOID RECEPTOR MODULATORS AND USE THEREOF<br/>[FR] MODULATEURS DES RÉCEPTEURS OPIOÏDES ET LEUR UTILISATION
申请人:UNIV MINNESOTA
公开号:WO2017039778A1
公开(公告)日:2017-03-09
Disclosed is an in vitro screening method for identifying an antagonist-to-agonist allosteric modifier of a mu-opioid receptor and an in vivo method for confirming that a test compound is such a modifier of a mu-opioid receptor. Also disclosed is a method for treating an opioid receptor-associated condition using a compound of Formula (I) and a pharmaceutical composition containing the same.
Cyclic Guanidines; V.<sup>1</sup>Synthesis of Novel Benzodiazepinoid and Related Systems by Intramolecular Electrophilic Aromatic Substitution
A convenient route to pentacyclic benzodiazepines and quinoxalines is reported, which simultaneously represent cyclic guanidines. Five new heterocyclic ring systems are described and the rules governing the regioselectivity of some of the ring closure reactions are studied. The structure of one of the products is confirmed by X-ray analysis. Scope and versatility of the process are indicated by several examples.